Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Endocrinology · Functional Endocrine Tumor

Endocrine Tumors: Why Do They Cause Weight Gain & High BP?

At a Glance

Functional endocrine tumors overproduce hormones, causing severe body-wide changes. Excess cortisol causes Cushing's syndrome, leading to rapid weight gain, while excess adrenaline from a pheochromocytoma causes dangerous blood pressure spikes. Treatment usually involves targeted surgical removal.

The endocrine system is a network of glands that produce and release hormones—chemical messengers that control almost every function in your body. When a tumor forms in one of these glands, it can become what doctors call a functional tumor. This means the tumor acts like a rogue factory, ignoring the body’s normal control signals and pumping out large, unregulated amounts of hormones [1]. Because hormones are powerful and circulate throughout your entire bloodstream, even a small tumor can cause dramatic, full-body symptoms like sudden weight gain or severe high blood pressure.

Why Tumors Cause Specific Symptoms

The specific symptoms you experience depend entirely on which hormone the tumor is overproducing. While functional tumors can occur in many glands—including the pancreas, thyroid, or parathyroid—two of the most common and dramatic hormone-driven conditions are Cushing’s syndrome and pheochromocytoma.

When Tumors Cause Too Much Cortisol (Cushing’s Syndrome)

Cortisol is often called the body’s “stress hormone.” It helps regulate your metabolism, reduce inflammation, and manage your sleep-wake cycle. When your body is exposed to excessive amounts of cortisol, it causes a condition called Cushing’s syndrome.

This hormone overload can happen in two main ways. It can occur directly if a tumor in the adrenal glands (above the kidneys) makes too much cortisol itself. It can also occur indirectly if a tumor in the pituitary gland (at the base of the brain) produces too much ACTH (adrenocorticotropic hormone)—a signal that forces the adrenal glands to overproduce cortisol [2][3].

Prolonged, high levels of cortisol completely alter how your body stores fat and processes energy [4]. This is why patients with Cushing’s syndrome often experience rapid, unexplained weight gain [5]. The excess cortisol directs the body to store fat in very specific areas, leading to a rounder face (sometimes called a “moon face”) and extra fat around the midsection or the back of the neck, while the arms and legs may remain thin [5]. Cortisol overproduction also disrupts blood vessel function and glucose control, making high blood pressure and high blood sugar hallmarks of the condition [6].

When Tumors Make Too Much Adrenaline (Pheochromocytoma)

Pheochromocytomas are rare tumors that usually form in the center of the adrenal glands. These tumors overproduce catecholamines—hormones like adrenaline and noradrenaline, which are responsible for the body’s “fight-or-flight” response [7].

Normally, your body releases these hormones in brief bursts when you are in danger or under extreme stress, causing your heart to race and your blood vessels to constrict. A pheochromocytoma, however, causes a continuous or episodic release of these hormones without any external trigger [7][8].

Because your cardiovascular system is constantly being stimulated by adrenaline, you can experience sudden and severe spikes in blood pressure (paroxysmal hypertension), a rapid or pounding heartbeat (tachycardia), and heavy sweating (diaphoresis) [9]. For many patients, these symptoms occur in frightening, unpredictable “attacks” or episodes, although some people experience constant high blood pressure [9][8].

Testing and Treatment: What to Expect

Experiencing symptoms like a racing heart, sudden weight gain, or uncontrollable blood pressure can be deeply unsettling. It is completely normal to feel frustrated, especially since these physical symptoms are often mistaken for general stress, poor diet, or panic attacks before the tumor is discovered.

Understanding that a specific, physical cause—a hormone-producing tumor—is driving these changes is the first step toward getting relief. To identify exactly which hormone is out of balance, your doctor will order specific diagnostics. For Cushing’s syndrome, this often involves a 24-hour urinary free cortisol test or a late-night salivary cortisol test [10][11]. To test for a pheochromocytoma, your care team will likely look for byproducts of adrenaline using blood tests for plasma-free metanephrines or a 24-hour urine test [12][13].

Once the specific hormone is identified, your care team can tailor a treatment plan, which often involves removing the tumor entirely. However, the path to surgery requires careful medical management:

  • Preparing for Surgery: For a pheochromocytoma, you cannot go straight to surgery. You will first need specialized medications called alpha-blockers to stabilize your blood pressure and prevent a dangerous adrenaline spike during the operation [14][15].
  • Life After Removal: If you have a tumor removed for Cushing’s syndrome, the normal parts of your glands may have “gone to sleep” due to the tumor doing all the work. It can take months or even years for your natural hormone production to fully wake back up, and you may need temporary hormone replacement medication during this recovery period [16][3].

Common questions in this guide

Why does an endocrine tumor cause sudden weight gain?
Some endocrine tumors produce excess cortisol, leading to Cushing's syndrome. This high level of cortisol changes how your body stores fat, often causing rapid weight gain around the midsection, back of the neck, and face.
Can a tumor cause severe high blood pressure?
Yes, a rare tumor called a pheochromocytoma can cause severe high blood pressure. These tumors overproduce adrenaline, which constantly stimulates your cardiovascular system and can cause dangerous blood pressure spikes, a racing heart, and heavy sweating.
How do doctors test for a hormone-producing tumor?
Doctors use specific blood, urine, or saliva tests to measure your hormone levels. For example, a 24-hour urine test can check for excess cortisol or adrenaline byproducts to pinpoint exactly which hormone is out of balance.
Will I need medication before surgery to remove a pheochromocytoma?
Yes, before surgery to remove a pheochromocytoma, you must take specialized medications called alpha-blockers. These drugs stabilize your blood pressure and prevent life-threatening adrenaline spikes during the operation.
What happens to my hormone levels after the tumor is removed?
After removing a hormone-producing tumor, your normal glands may need time to 'wake up' and start producing hormones naturally again. You may require temporary hormone replacement therapy for months or years while your body recovers.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific tests (such as 24-hour urine tests or blood panels) are you ordering to pinpoint exactly which hormone is out of balance?
  2. 2.If my symptoms suggest a pheochromocytoma, what is the plan for medical preparation (like alpha-blockers) before any surgery is attempted?
  3. 3.How much experience does this surgical team have with removing functional endocrine tumors?
  4. 4.If the tumor is removed, will my body need temporary or permanent hormone replacement therapy while my remaining glands wake back up?
  5. 5.Are there other hormone levels we should be checking based on my symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Pachychoroid Spectrum Diseases in Patients with Cushing's Syndrome: A Systematic Review with Meta-Analyses.

    Holtz JK, Larsson JME, Hansen MS, et al.

    Journal of clinical medicine 2022; (11(15)) doi:10.3390/jcm11154437.

    PMID: 35956052
  2. 2

    Insights on epidemiology, morbidity and mortality of Cushing's disease in Northern Ireland.

    Loughrey PB, Herron B, Cooke S, et al.

    Endocrine-related cancer 2024; (31(9)).

    PMID: 38889004
  3. 3

    Cushing Disease: Medical and Surgical Considerations.

    Bray DP, Rindler RS, Dawoud RA, et al.

    Otolaryngologic clinics of North America 2022; (55(2)):315-329 doi:10.1016/j.otc.2021.12.006.

    PMID: 35256173
  4. 4

    Hypertension and Cardiovascular Mortality in Patients with Cushing Syndrome.

    Nieman LK

    Endocrinology and metabolism clinics of North America 2019; (48(4)):717-725 doi:10.1016/j.ecl.2019.08.005.

    PMID: 31655772
  5. 5

    Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity.

    Araujo-Castro M, Pascual-Corrales E, Lamas C

    Annales d'endocrinologie 2023; (84(2)):272-284 doi:10.1016/j.ando.2023.01.005.

    PMID: 36736771
  6. 6

    Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.

    Fallo F, Di Dalmazi G, Beuschlein F, et al.

    Journal of hypertension 2022; (40(11)):2085-2101 doi:10.1097/HJH.0000000000003252.

    PMID: 35950979
  7. 7

    Anesthetic challenges in bilateral pheochromocytoma with history of percutaneous transluminal coronary angioplasty (PTCA): A case report and literature review.

    Bhiwal AK, Patidar NC, Vyas AS, Bhokan RR

    Saudi journal of anaesthesia 2022; (16(2)):240-242 doi:10.4103/sja.sja_760_21.

    PMID: 35431728
  8. 8

    Pheochromocytoma in a 49-year-old woman presenting with acute myocardial infarction: A case report.

    Wu HY, Cao YW, Gao TJ, et al.

    World journal of clinical cases 2021; (9(15)):3752-3757 doi:10.12998/wjcc.v9.i15.3752.

    PMID: 34046479
  9. 9

    PHEOCHROMOCYTOMA, THE GREAT MASQUERADER, PRESENTING AS REVERSIBLE CARDIOMYOPATHY: PRIMUM NON NOCERE.

    Boro H, Sharma H, Mittal D, et al.

    Acta endocrinologica (Bucharest, Romania : 2005) 2023; (19(3)):370-375 doi:10.4183/aeb.2023.370.

    PMID: 38356978
  10. 10

    Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology.

    Ceccato F, Terzolo M, Gatto F, et al.

    Journal of endocrinological investigation 2025; doi:10.1007/s40618-025-02758-3.

    PMID: 41364328
  11. 11

    Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?

    Ferriere A, Tabarin A

    Current opinion in endocrinology, diabetes, and obesity 2025; (32(5)):233-239 doi:10.1097/MED.0000000000000923.

    PMID: 40747969
  12. 12

    Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

    Därr R, Kuhn M, Bode C, et al.

    Endocrine 2017; (56(3)):495-503 doi:10.1007/s12020-017-1300-y.

    PMID: 28405881
  13. 13

    Is It Enough to Diagnose Pheochromocytoma by Measuring Urine Metanephrines Levels?

    Houssein M, Aydın C, Köroğlu EY, et al.

    Cureus 2024; (16(9)):e69560 doi:10.7759/cureus.69560.

    PMID: 39421117
  14. 14

    MANAGEMENT STRATEGIES FOR NORMOTENSIVE PHEOCHROMOCYTOMA IN PREGNANCY.

    Parksook WW, Panumatrassamee K, Phupong V, Snabboon T

    Acta endocrinologica (Bucharest, Romania : 2005) 2024; (20(4)):533-537 doi:10.4183/aeb.2024.533.

    PMID: 41069528
  15. 15

    The Perioperative Biochemical and Clinical Considerations of Pheochromocytoma Management.

    Gombert AJ, Nerantzinis AM, Li J, et al.

    International journal of molecular sciences 2025; (26(13)) doi:10.3390/ijms26136080.

    PMID: 40649858
  16. 16

    High recovery rate of adrenal function after successful surgical treatment of Cushing's syndrome.

    van de Ven AC, van Houten P, Grevers L, et al.

    Endocrine connections 2025; (14(5)).

    PMID: 40127454

This page is for informational purposes only and does not replace professional medical advice. Always consult your endocrinologist or healthcare provider to evaluate sudden weight gain, severe high blood pressure, or other unexplained symptoms.

Get notified when new evidence is published on Tumor of endocrine glands.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.